Transcatheter aortic valve implantation for patients with aortic stenosis: A scientific statement from the Italian Federation of Cardiology (FIC) and the Italian Society for Cardiac Surgery (SICCH);Impianto transcatetere di protesi valvolare aortica in pazienti con stenosi valvolare severa sintomatica: Documento di Consenso Federazione ltaliana di Cardiologia (FIC) - Società ltaliana di Chirurgia Cardiaca (SICCH)

Giornale Italiano di Cardiologia

Volumn 11, Issue 1, 2010, Pages 45-53

  Santoro, Gennaro ^a   Vitali, Ettore ^b   Tamburino, Corrado ^c   Quaini, Eugenio ^d   Ramondo, Angelo ^e   Pizzuto, Francesco ^f   Innocenti, Daniela ^a   Di Pasquale, Giuseppe ^g  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b Humanitas Gavazzeni Hospital   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d Società Italiana di Chirurgia Pediatriaca   (Italy)

^e UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTERY CALCIFICATION; CARDIOLOGIST; CARDIOLOGY; CARDIOVASCULAR RISK; CHEMOEMBOLIZATION; CONFERENCE PAPER; HEART SURGERY; HUMAN; MEDICAL SOCIETY; PREVALENCE; PROGNOSIS;

AORTIC VALVE STENOSIS; ELECTROCARDIOGRAPHY; EVIDENCE-BASED MEDICINE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; ITALY; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; SOCIETIES, MEDICAL; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 76749108059     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thorecic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008; 29: 1463-70.
2. Nkomo VT, Gardin JM, Skeleton TN, Gottdiener JS, Scott CG, Enriquez-Sareno M. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005-11.
3. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovasculer Health Study. J Am Coll Cardiol 1997; 29: 630-4.
4. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21: 1220-5.
5. Gilbert T, Orr W, Banning AP. Surgery for aortic stenosis in severely symptomatic patients older than 80 years: experience in a single UK centre. Heart 1999; 82: 138-42.
6. Melby SJ, Zierer A, Kaiser SP, et al. Aortic valve replacement in octogenarians: risk factors for early and late mortality. Ann Thorac Surg 2007; 83: 1651-7.
7. lung B, Baron G, Butchart EG, et el. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J 2003; 24: 1231-43.
8. Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006; 82: 2111-5.
9. Novaro GM, Ketz R, Aviles RJ, et el. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. J Am Coll Cardiol 2007; 50: 1992-8.
10. Palta S, Pai AM, Gill KS, Pei RG. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation 2000; 101: 2497-502.
11. Cribier A, Eltchaninoff H, Bash A, et el. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106: 3006-8.
12. Rosengart TK, Feldman T, Borger MA, et al. Percutaneous and minimally invasive valve procedures: a scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translation Biology Inter-disciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2008; 117: 1750-67.
13. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52: e1-e142.
14. Brown JM, O'Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108 687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009; 137: 82-90.
15. Blackstone EH, Cosgrove DM, Jamieson WR, et al. Prosthesis size and long-term survival after aortic valve replacement. J Thorac Cardiovasc Surg 2003; 126: 783-96.
16. Mihaljevic T, Nowicki ER, Rajeswaran J, et al. Survival after valve replacement for aortic stenosis: implications for decision making. J Thorac Cardiovasc Surg 2008; 135: 1270-9.
17. Mehta RH, Bruckman D, Das S, et al. Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg 2001; 122: 919-28.
18. Ding WH, Lam YY, Pepper JR, et al. Early and long-term survival after aortic valve replacement in septuagenarians and octogenarians with severe aortic stenosis. Int J Cardiol 2009, in press.
19. Thourani VH, Myung R, Kilgo P, et el. Long-term outcomes after isolated aortic valve replacement in octogenarians: a modern perspective. Ann Thorac Surg 2008; 86: 1458-64.
20. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005; 111: 3290-5.
21. Dewey TM, Brown DL, Das TS, et al. High-risk patients referred for transcatheter aortic valve implantation: management and outcomes. Ann Thorac Surg 2008; 86: 1450-6.
22. Roques F, Nashef SA, Michel P, for the EuroSCORE Study Group. Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EurosCORE pilot program. J Heart Valve Dis 2001; 10: 572-7.
23. STS US Cardiac Surgery Database. 1997 Aortic valve replacement patients: preoperative risk variables. Chicago, IL: Society of Thoracic Surgeons, 2000. http://www.ctsnet.org/doc/3031[accessed August 28, 2009].
24. Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, Taylor KM. Generic, simple risk stratification model for heart valve surgery. Circulation 2005; 112: 224-31.
25. De Jaegere P, Van Dijk LC, Laborde JC, et al. True percutaneous implantation of the CoreValve aortic valve prosthesis by the combined use of ultrasound guided vascular access, Prostar® XL and the TandemHeart®. EuroIntervention 2007; 2: 500-5.
26. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004; 43: 698-703.
27. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies. The French experience. J Am Coll Cardiol 2006; 47: 1214-23.
28. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006; 114: 1616-24.
29. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006; 113: 842-50.
30. Webb JG, Pasupati S, Humphries K, et el. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755-63.
31. Grube E, Schuler G, Buellesfeld L, et el. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007; 50: 69-76.
32. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006; 114: 591-6.
33. Walther T, Falk V, Borger MA, et el. Minimally invasive transventricular beating heart aortic valve implantation - proof of concept. Eur J Cardiothorac Surg 2007; 31: 9-15.
34. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007; 116 (11 Suppl): 1240-1245.
35. Ye J, Cheung A, Lichtenstein SV, et al. Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg 2007; 31: 16-21.
36. Budoff MJ, Takasu J, Ketz R, et el. Reproducibility of CT measurements of aortic valve calcification, mitral annulus calcification, and aortic wall calcification in the multi-ethnic study of atherosclerosis. Acad Radiol 2006; 13: 166-72.
37. Tops LF, Wood DA, Delgado V, et el. Noninvasive evaluation of the aortic root with multislice computed tomography: implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging 2008; 1: 321-30.
38. Chiappini B, Camurri N, Loforte A, Di Marco L, Di Bartolomeo R, Marinelli G. Outcome after aortic valve replacement in octogenarians. Ann Thorac Surg 2004; 78: 85-9.
39. Brown ML, Schaff HV, Serano ME, et al. Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? J Thorac Cardiovascular Surg 2008; 136: 566-71.
40. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755-63.
41. Grober E, Hall C, Lipton RB, Teresi JA. Primary care screen for early dementia. J Am Gerietr Soc 2008; 56: 206-13.
42. Zegdi R, Ciobotaru V, Noghin M, et al. Is it reasonable to treat all calcified stenotic aortic valve s with a valved stent? Results from a human anatomic study in adults. J Am Coll Cardiol 2008; 51: 579-84.
43. Shumaker SA, Anderson RT, Czajkowski SM. Psychological tests and scales. In: Spilker B, ed. Quality of life assessments in clinical trials. New York, NY: Raven Press, 1990: 95-113.
44. Elkinton JR. Medicine and the quality of life. Ann Intern Med 1966; 64: 711-4.
45. Walter PJ, Mohan R, Amsel BJ. Quality of life after heart valve replacement. J Heart Valve Dis 1992; 1: 34-41.
46. Olsson M, Janfjall H, Orth-Gomer K, Unden A, Rosenqvist M. Quality of life in octogenarians after valve replacement due to aortic stenosis. A prospective comparison with younger patients. Eur Heart J 1996; 17: 583-9.
47. Khan JH, McElhinney DB, Hall TS, Merrick SH. Cardiac valve surgery in octogenarians: improving quality of life and functional status. Arch Surg 1998; 133: 887-93.
48. Huber CH, Goeber V, Berdat P, Carrel T, Eckstein F. Benefits of cardiac surgery in octogenarians - a postoperative quality of life assessment. Eur J Cardiothorac Surg 2007; 31: 1099-105.